PHIN2008-2 : Clinical viewpoints

Study Programmes 2015-2016

PHIN2008-2

Clinical viewpoints

Metabolising medication and pharmacokinetic limits
Theoretical and practical views on clinical studies (including the statistical methods applied to clinical studies)
Information and adverse drug events monitoring

Duration :

Metabolising medication and pharmacokinetic limits : 20h Th
Theoretical and practical views on clinical studies (including the statistical methods applied to clinical studies) : 15h Th
Information and adverse drug events monitoring : 10h Th

Number of credits :

Specialised master in industrial pharmacy		6

Lecturer :

Metabolising medication and pharmacokinetic limits : Roger Verbeek
Theoretical and practical views on clinical studies (including the statistical methods applied to clinical studies) : Régis Radermecker
Information and adverse drug events monitoring : Raphaël Denooz

Coordinator :

Philippe Hubert

Language(s) of instruction :

French language

Units courses prerequisite and corequisite :

Prerequisite or corequisite units are presented within each program

Course contents :

Information and adverse drug events monitoring

This course is dedicated to some notions of Information and Publicity in the field of therapeutic drugs. Pharmacovigilancy aspects are also approached. (Definition and imputability criteria of adverse drugs effects, CBPH operating, ...)

Learning outcomes of the course :

Information and adverse drug events monitoring

Table of contents:
1. Pharmacovigilancy: Evaluation of the therapeutic risk
2. Pharmacovigilancy in Belgium and in Europe
3. Information and Publicity

Prerequisite knowledge and skills :

Information and adverse drug events monitoring

Toxicology course of the second cycle

Planned learning activities and teaching methods :

Information and adverse drug events monitoring

Pointless

Mode of delivery (face-to-face ; distance-learning) :

Information and adverse drug events monitoring

3 courses of 3 or 4 hours

Recommended or required readings :

Information and adverse drug events monitoring

PowerPoint slides

Assessment methods and criteria :

Information and adverse drug events monitoring

Written evalation in january

Work placement(s) :

Organizational remarks :

Contacts :

Information and adverse drug events monitoring

Dr Raphaël DENOOZ
Clinical and Forensic Toxicological laboratory
CHU B35
Sart-Tilman, B4000 Liège
Tél.04/3667683
Fax 04/3668889
e-mail : Raphael.Denooz@chu.ulg.ac.be